# Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

> **NCT01933035** · — · COMPLETED · sponsor: **Beth Israel Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Immune Thrombocytopenia
- Chemotherapy Induced Thrombocytopenia
- Myelodysplasia
- Aplastic Anaemia

## Interventions

- **OTHER:** Immune Thrombocytopenics
- **OTHER:** Hypo-proliferative thrombocytopenics
- **OTHER:** Control Population

## Key facts

- **NCT ID:** NCT01933035
- **Lead sponsor:** Beth Israel Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2016-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01933035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01933035, "Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01933035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*